Join Now

Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

By Press Release | Published February 1, 2024

Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

Posted in BioUtah News | Tagged | Comments Off on Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

Unveiling the Power of Epigenetics in Male Fertility: A New Horizon Beyond Semen Analysis

By Press Release | Published October 26, 2023

Unveiling the Power of Epigenetics in Male Fertility: A New Horizon Beyond Semen Analysis

Posted in BioUtah News | Tagged | Comments Off on Unveiling the Power of Epigenetics in Male Fertility: A New Horizon Beyond Semen Analysis

Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH

By Press Release | Published August 17, 2023

A Leap Forward for Patients, a Promising Opportunity for Investors, and a Revolutionary Tool for Physicians

Posted in BioUtah News | Tagged | Comments Off on Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH

Inherent Biosciences Partners With Posterity Health to Accelerate the Path to Parenthood by Elevating the Standard of Care in Male Reproductive Health

By Press Release | Published January 10, 2023

Inherent Biosciences has teamed up with Posterity Health, the only virtual Male Fertility Center of Excellence, to address male fertility

Posted in BioUtah News | Tagged | Leave a comment

Inherent Biosciences awarded NIH SBIR Phase I Grant to commercialize innovative diagnosis of non-obstructive azoospermia (the most severe form of sperm dysfunction)

By Press Release | Published April 14, 2022

Inherent Biosciences announced an award from the National Institute of Child Health and Human Development’s Fertility and Infertility Branch to develop a clinical assay for improved diagnosis of non-obstructive azoospermia (NOA).

Posted in BioUtah News | Tagged | Leave a comment

Inherent Biosciences Launches Path Fertility – Epigenetic Sperm Quality Test (SpermQT)

By Press Release | Published October 19, 2021

SpermQT analyzes the molecular function of sperm and is 6x more predictive of fertility potential than standard semen analysis.

Posted in BioUtah News | Tagged | Leave a comment

A Special Thanks To Our Elite Members